41 related articles for article (PubMed ID: 12955746)
1. Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses.
Livesay EA; Tang K; Taylor BK; Buschbach MA; Hopkins DF; LaMarche BL; Zhao R; Shen Y; Orton DJ; Moore RJ; Kelly RT; Udseth HR; Smith RD
Anal Chem; 2008 Jan; 80(1):294-302. PubMed ID: 18044960
[TBL] [Abstract][Full Text] [Related]
2. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.
Wang Z; Hop CE; Leung KH; Pang J
J Mass Spectrom; 2000 Jan; 35(1):71-6. PubMed ID: 10633236
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
4. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.
Luippold AH; Arnhold T; Jörg W; Krüger B; Süssmuth RD
J Biomol Screen; 2011 Mar; 16(3):370-7. PubMed ID: 21335598
[TBL] [Abstract][Full Text] [Related]
5. A computer program for automated data evaluation to support in vitro higher-throughput screening for drug metabolism and pharmacokinetics attributes.
Fung EN; Chu I; Nomeir AA
Rapid Commun Mass Spectrom; 2004; 18(18):2046-52. PubMed ID: 15378716
[TBL] [Abstract][Full Text] [Related]
6. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
[TBL] [Abstract][Full Text] [Related]
7. Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system.
Fung EN; Chu I; Li C; Liu T; Soares A; Morrison R; Nomeir AA
Rapid Commun Mass Spectrom; 2003; 17(18):2147-52. PubMed ID: 12955746
[TBL] [Abstract][Full Text] [Related]
8. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
Shou WZ; Zhang J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
[TBL] [Abstract][Full Text] [Related]
9. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
Castro-Perez JM
Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
[TBL] [Abstract][Full Text] [Related]
10. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s.
Youdim KA; Saunders KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1326-36. PubMed ID: 20207203
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
Ma S; Zhu M
Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
